Boston Scientific received approval of its fourth generation Vercise Genus Deep Brain Stimulation (DBS) System. The portfolio, approved for conditional use in a magnetic resonance imaging (MRI) environment, consists of a family of Bluetooth-enabled, rechargeable and non-rechargeable, implantable pulse generators (IPGs) that power Cartesia directional leads.
DBS devices can treat the symptoms of Parkinson’s Disease (PD) by delivering targeted electrical stimulation via surgically implanted leads in the brain connected to an IPG. http://www.bostonscientific.com/dbs
Dakota ACDF is indicated for use in skeletally mature patients with DDD of the cervical spine (C2-T1) at one or two disc levels with DDD defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. https://www.precisionspineinc.com
Longeviti Neuro Solutions received 510(k) clearance for the ClearFit implant for post-operative imaging using ultrasound. A neuro reconstructive implant used by surgeons to reconstruct a patient’s cranium, ClearFit implants are implantable, patient-specific prosthetics. The company’s innovative solutions for complex brain surgery is advancing neurosurgery using low-profile intracranial devices that address the functional and reconstructive needs of patients with neurological conditions. https://longeviti.com
Explore the April 2021 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Forkardt Hardinge strengthens market position with ATS Systems acquisition
- July is for learning – so drop in for this month’s second Manufacturing Lunch + Learn
- MMT expands capabilities with acquisition of Comco
- Essential strategies to protect your data
- TT Electronics achieves ISO 13485 medical certification at Mexicali EMS facility
- Boost productivity with Nidec's innovative MGC300
- Meet AEON: the future of humanoid robotics
- Okuma: Extraordinary Starts Where Limits End
